Bases inmunologicas de la vacunacion ADN ESME

Introduction to Immunological Phases of Vaccination

Overview of the Seminar

• The seminar focuses on immunological phases of vaccination, types of vaccines, their components, and mechanisms of action. It aims to explain the immune response associated with vaccinations and key concepts in immunology.

Key Concepts in Immunology

• Discussion includes effector mechanisms involved in immune responses related to vaccines, including collaboration between T cells and antibody-mediated immunity.

• Characteristics that define antigens are highlighted, differentiating between thymus-dependent and thymus-independent antigens. The kinetics of immune responses is also addressed.

Mechanisms of Immune Response

Classification and Control of Pathogens

• The immune system classifies aggressors based on morphological characteristics and molecular factors associated with pathogens using pattern recognition receptors (PRRs). This classification helps control intracellular agents like bacteria and viruses through inflammation or programmed cell death (apoptosis).

Role of Antibodies

• Antibodies neutralize toxins from pathogens; neutralizing antibodies are crucial for controlling infections. Adaptive immunity involves T lymphocytes that direct appropriate immune responses against specific antigens.

Activation and Proliferation of Lymphocytes

Antigen Presentation

• Activation requires professional antigen-presenting cells (APCs), such as dendritic cells, which present antigens to naïve T lymphocytes via major histocompatibility complex (MHC) molecules. This interaction initiates cellular activation and proliferation against the antigen presented.

Collaboration Between Lymphocyte Types

• Activated T helper cells assist B lymphocytes in producing antibodies by promoting differentiation into plasma cells while also generating memory B cells for future exposures to the same antigen. This collaboration is essential for effective adaptive immunity.

Immune Responses: Primary vs Secondary

Differences in Immune Responses

• Primary immune responses are characterized by a slower onset with IgM predominance, while secondary responses are faster, more robust, predominantly involving IgG production due to memory cell activation from previous exposures to the same antigen.

Kinetics of Immune Response

• The primary response consists of latency, exponential growth, stability, and decline phases; whereas secondary responses exhibit shorter latency periods with rapid increases in antibody titers due to pre-existing memory cells ready for immediate action upon re-exposure to an antigen.

Factors Influencing Immunogenicity

Determinants of Immunogenicity

• Three main factors influence whether an antigen is immunogenic: its physicochemical nature (molecular weight, complexity), genetic characteristics of the host (individual variability), and route/administration method affecting how it interacts with the immune system.

Types of Antigens

• Distinction between thymus-dependent antigens (typically proteins requiring T-cell help for B-cell activation) versus thymus-independent antigens (usually polysaccharides that can activate B-cells directly but often result in weaker memory).

Enhancing Vaccine Efficacy

Conjugate Vaccines

• Strategies such as conjugating polysaccharide antigens with protein carriers enhance immunogenicity by enabling T-cell involvement leading to stronger B-cell responses capable of generating long-lasting immunity through memory formation.

Importance of Memory Cells

• Memory B-cells generated during initial exposure provide a rapid response upon subsequent encounters with the same pathogen; this mechanism underlines vaccine effectiveness by ensuring quicker antibody production when faced again with familiar antigens.

This structured summary captures critical insights from the transcript regarding vaccination's immunological basis while providing timestamps for easy reference back to specific sections within the content.

Immune Memory and Vaccination Mechanisms

Immune Response Dynamics

• T-dependent responses require collaboration between follicular T lymphocytes and B cells, leading to the selection of memory T cells and plasma blasts. Some short-lived plasma cells are generated, while re-stimulated memory T cells produce long-lived plasma blasts that migrate to the bone marrow.

• B1 lymphocytes or marginal zone B cells generate short-lived plasma cells, resulting in limited immune response and memory against antigens. The duration of immune memory is influenced by factors such as antigen load, type, response type, and inoculation site.

• Various immunoglobulin types (IgM, IgE, IgG) have different half-lives; without re-stimulation or sustained production, antibody levels drop significantly after three weeks. Long-lived plasma cells in the bone marrow maintain protective antibody levels for years.

Secondary Immune Responses

• Memory lymphocytes can produce 8 to 10 times more plasma cells during secondary responses due to their longer lifespan. This allows for sustained protective antibody levels throughout life.

• Vaccination aims to establish immune memory through intense and durable secondary responses that prevent clinical infections upon exposure to pathogens.

Vaccine Design Considerations

• Effective vaccines should be good immunogens that activate antigen-presenting cells (APCs), ensuring proper processing and activation of T lymphocytes for robust memory cell formation.

• Antigens must be recognized by T lymphocytes through multiple epitopes while persisting in lymphoid tissues where memory B cells can continue producing antibodies over time.

Vaccine Composition

• Vaccines may contain live attenuated microorganisms or parts of them (antigen fractions). These induce immune responses that control diseases by stimulating both humoral immunity (antibodies) and cellular immunity (T cell activation).

• Essential components of vaccines include stabilizers, preservatives like antibiotics to prevent bacterial growth during viral culture processes, enhancing safety profiles while boosting immunogenicity.

Types of Vaccines

• Vaccines are classified into systematic ones for community interest under national immunization programs and those applied based on individual needs or specific situations.

• Different vaccine types include live attenuated organisms which mimic wild infections with strong immune responses versus inactivated organisms requiring multiple doses for adequate immunity.

Immune Response Mechanisms

• Live attenuated vaccines elicit strong long-lasting immunity but may be contraindicated in immunocompromised individuals. In contrast, inactivated vaccines stimulate weaker responses but are safer across populations.

• Examples include live attenuated vaccines like measles-mumps-rubella (MMR), whereas examples of inactivated vaccines include tetanus-diphtheria pertussis combinations which often require booster shots for effective immunity.

Graphical Representation of Immune Responses

• Graphical analysis illustrates primary versus secondary antibody-mediated responses over time; second exposures lead to quicker activation and differentiation of both free T lymphocytes and antibody-producing plasma cells.

Memory Generation from Vaccination

• The generation of immune memory involves understanding antigen characteristics such as load and entry routes into APCs like dendritic cells which activate naïve T lymphocytes within secondary lymphatic organs.

• The longevity of immune memory varies based on the type of antigen involved; collaborative interactions between B and T lymphocytes yield different patterns affecting the duration and efficacy of produced antibodies.